Clinical trial 2129 - TREAT ctDNA
Elacestrant for treating ER+/HER2- breast cancer patients with ctDNA relapse (TREAT ctDNA)
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | EORTC |
| EudraCT Identifier | 2022-501453-36-00 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/05512364 |
| Last update |